Prosolus Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Debt - PPP
- Investors
-
2
Prosolus General Information
Description
Developer a transdermal drug delivery system intended for various therapeutic categories. The company specializes in transdermal patches, pain management, and cardiovascular and neurologic care and manufactures high-barrier-to-entry transdermal drug delivery products, enabling healthcare organizations to treat diseases effectively.
Contact Information
Website
www.prosoluspharma.comCorporate Office
- 6701 North West 7 Street
- Miami, FL 33126
- United States
Corporate Office
- 6701 North West 7 Street
- Miami, FL 33126
- United States
Prosolus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Debt - PPP | 09-Apr-2020 | Completed | Generating Revenue | |||
| 3. Merger/Acquisition | 02-Aug-2019 | Cancelled | Generating Revenue | |||
| 2. Secondary Transaction - Private | 30-Jun-2018 | Completed | Generating Revenue | |||
| 1. Merger/Acquisition | 29-May-2015 | Completed | Generating Revenue |
Prosolus Comparisons
Industry
Financing
Details
Prosolus Competitors (12)
One of Prosolus’s 12 competitors is Medherant, a Venture Capital-Backed company based in Coventry, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Medherant | Venture Capital-Backed | Coventry, United Kingdom | ||||
| Avenir Wellness Solutions | Formerly VC-backed | Oxnard, CA | ||||
| AdhexPharma | Corporation | Chenove, France | ||||
| Kindeva Drug Delivery | Private Equity-Backed | Woodbury, MN | ||||
| Rottendorf Pharma | Corporation | Ennigerloh, Germany |
Prosolus Patents
Prosolus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10010511-B2 | Transdermal drug delivery system | Inactive | 25-May-2016 | ||
| US-20170340577-A1 | Transdermal drug delivery system | Active | 25-May-2016 | ||
| US-10307380-B1 | Composition and method for transdermal lidocaine delivery | Inactive | 04-Mar-2014 | ||
| US-9408802-B1 | Seven day drug in adhesive transdermal delivery | Inactive | 22-Mar-2012 | ||
| US-20130214192-A1 | Coated seals | Active | 19-Jul-2007 | C09D4/00 |
Prosolus Signals
Prosolus Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bravos Capital | Fundless Sponsor | Minority | ||
| Mission Pharmacal | Corporation | Minority |
Prosolus FAQs
-
When was Prosolus founded?
Prosolus was founded in 2009.
-
Where is Prosolus headquartered?
Prosolus is headquartered in Miami, FL.
-
What is the size of Prosolus?
Prosolus has 11 total employees.
-
What industry is Prosolus in?
Prosolus’s primary industry is Drug Delivery.
-
Is Prosolus a private or public company?
Prosolus is a Private company.
-
What is Prosolus’s current revenue?
The current revenue for Prosolus is .
-
Who are Prosolus’s investors?
Bravos Capital and Mission Pharmacal have invested in Prosolus.
-
Who are Prosolus’s competitors?
Medherant, Avenir Wellness Solutions, AdhexPharma, Kindeva Drug Delivery, and Rottendorf Pharma are some of the 12 competitors of Prosolus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process